Jeffrey Tosoian, MD, MPH

Assistant Professor
Department of Urology
Director of Translational Cancer Research
Division of Urologic Oncology

Medical School: Johns Hopkins University School of Medicine
Residency: Johns Hopkins Medical Institutions
Fellowship: University of Michigan, Urologic Oncology and Translational Cancer Research
Clinical Interests: Elevated PSA, Prostate Cancer, Kidney Cancer, Bladder Cancer, Testis Cancer

Dr. Tosoian specializes in the surgical and non-surgical management of urologic cancers. His previous research demonstrated the safety of active surveillance for low-risk prostate cancer, contributing to its adoption in clinical guidelines as a first-line management option. His research is currently focused on the development and clinical application of diagnostic and prognostic tools to guide detection and management of prostate and other genitourinary cancers, including blood-, urine-, and tissue-based biomarkers.